Profile
Johannes C Scholtes has been Chairman & Chief Strategy Officer at ZyLAB North America LLC since 1989.
Since 2024, Dr. Scholtes has also been a Venture Partner at Endeit Capital BV.
Dr. Scholtes graduated from Delft University of Technology in 1987 and earned a doctorate from the University of Amsterdam in 1993.
Johannes Scholtes active positions
| Companies | Position | Start |
|---|---|---|
ZyLAB North America LLC
ZyLAB North America LLC Information Technology ServicesTechnology Services Provides information technology services | Chairman | 01/01/1989 |
Endeit Capital BV
Endeit Capital BV Investment ManagersFinance Endeit Capital invests in companies located across Europe primarily in Germany, the Netherlands and Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early and later stage capital requirements with an investment EUR 5 -20 million. | Private Equity Investor | 01/11/2024 |
Training of Johannes Scholtes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Amsterdam
University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ZyLAB North America LLC
ZyLAB North America LLC Information Technology ServicesTechnology Services Provides information technology services | Technology Services |
Delft University of Technology
Delft University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endeit Capital BV
Endeit Capital BV Investment ManagersFinance Endeit Capital invests in companies located across Europe primarily in Germany, the Netherlands and Sweden. The firm targets companies operating across a broad range of sectors and industries. It provides financing for early and later stage capital requirements with an investment EUR 5 -20 million. | Finance |
- Stock Market
- Insiders
- Johannes Scholtes
















